CareMax (CMAX) Tops Q3 EPS by 102c ; Offers Guidance

CareMax (NASDAQ: CMAX) reported Q3 EPS of $0.92, $1.02 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $201.8 million versus the consensus estimate of $193.88 million.

GUIDANCE:

CareMax sees FY2023 revenue of $750-800 million, versus the consensus of $783.8 million.

For earnings history and earnings-related data on CareMax (CMAX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery